Area for improvement | Target |
---|---|
Diagnostic phase | |
1 Increase availability of biopsy report | > 95% availability of reports |
2 Standardise MRI report | > 85% of reports meet Mercury Study Group criteria* (ICS-IDI diagnostic imaging service) |
3 Increase multidisciplinary working (treatment strategy) | > 85% of patients diagnosed at ICO have cases reviewed by tumour board |
Treatment phase | |
1 Standardise criteria for indicating radiotherapy (IMRT)† | > 85% of patients with indication for radiotherapy are treated with IMRT |
2 Improve adherence to planned RT treatment (OTT) | |
Develop protocol for managing treatment interruptions | Approve protocol by October 2016 and implement it |
Disseminate and apply protocol | Reduce % of patients with prolonged OTT |
Reduce % of patients finalising treatment on Monday | |
3 Standardise criteria for imaging controls during treatment | |
Develop protocol for imaging controls during treatment (IGRT) | Approve protocol by October 2016 and implement it |
Disseminate and apply protocol | > 85% of patients with imaging control according to protocol |
4 Standardise anatomical pathology report (surgical specimen): report ypCRM | > 85% of pathology reports note ypCRM |
Follow-up phase | |
1 Report adverse effects according to severity, based on CTCAE (v4.0) classifications | > 85% of follow-up visits record presence or absence of adverse events and their CTCAE grade during the clinical course |